OTR Therapeutics

Catalyzing early innovation into global impactful therapies

Shanghai, China · Founded 2025 · $100.0M raised

Headquarters
Shanghai
Employees
1–10
Founded
2025
Business Model
B2B
Website
otr-tx.com
Total Funding
$100.0M
Last Round
$100.0M Series AJun 2025
Rounds
1

About

OTR Therapeutics is a Shanghai-based biotechnology company dedicated to transforming early-stage innovations into globally impactful therapies for critical diseases with high unmet medical needs. The company focuses on oncology, immunology and inflammation, and cardiometabolic diseases, combining internal discovery with strategic acquisition of preclinical and early-stage assets. Founded in March 2025, it raised a $100M Series A backed by Temasek's True Light Capital, LAV, Pfizer Ventures, and Sirona Capital.

Summary

OTR Therapeutics is a Biotech company based in Shanghai, China, founded in 2025. It has raised $100.0M in total across 1 round, most recently a $100.0M Series A round in Jun 2025. Investors include True Light Capital, Temasek and Pfizer Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AJun 2025
$100.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

OTR Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/otr-therapeutics"><img src="https://indexed.vc/api/badge/company/otr-therapeutics" alt="OTR Therapeutics on Indexed.vc" width="260" height="76" /></a>